HEALTHCARE
Global Eubiotics Market - Industry Trends and Forecast to 2032
REPORT OVERVIEW
Global Eubiotics Market, By Product (Probiotics, Prebiotics, Organic Acids, Phytogenic, and Enzymes), Form (Liquid and Solid), Application (Gut Health, Immunity, Yield, and Others), End Use (Cattle Feed, Poultry Feed, Swine Feed, Aquatic Feed, and Others), Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2032.
Market Insights
Market Dynamics
- Expansion in poultry and swine sectors
- Demand for performance enhancement
- Limited awareness
- Resistance to change
- Integration with digital agriculture
- Development of tailored solutions
- Quality and stability issues
- Supply chain vulnerabilities
SEGMENTATION
- Product
- Probiotics
- Lactobacilli
- Bifidobacterium
- Streptococcus
- Others
- Prebiotics
- Fructo-oligosaccharides (FOS)
- Inulin
- Galacto-Oligosaccharides (GOS)
- Mannan-Oligosaccharides (MOS)
- Others
- Organic Acids
- Phytogenic
- Enzymes
- Form
- Liquid
- Solid
- Application
- Gut Health
- Immunity
- Yield
- Others
- End Use
- Cattle Feed
- Poultry Feed
- Swine Feed
- Aquatic Feed
- Others
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- The Netherlands
- Belgium
- Turkey
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Singapore
- Malaysia
- Australia
- Thailand
- Philippines
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Chile
- Colombia
- Rest of South America
- Middle East and Africa
- Kingdom of Saudi Arabia
- South Africa
- U.A.E.
- Egypt
- Rest of Middle East and Africa
KEY MARKET PLAYERS
- DSM
- Novus International, Inc.
- UAS Laboratories
- Lallemand, Inc.
- Calpis Co., Ltd.
- Advanced BioNutrition Corp
- BENEO
- BEHN MEYER
- Lesaffre Group
- Kemin Industries, Inc.
Table OF CONTENTS
- SECTION 1 - INTRODUCTION
- 1.1 Taxonomy
- 1.2 Market Overview
- 1.3 Currency and Limitations
- 1.3.1 Currency
- 1.3.2 Limitations
- 1.4 Key Competitors
- SECTION 2 - RESEARCH METHODOLOGY
- 2.1 Research Approach
- 2.2 Data Collection and Validation
- 2.2.1 Secondary Research
- 2.2.2 Primary Research
- 2.3 Market Assessment
- 2.3.1 Market Size Estimation
- 2.3.2 Bottom-up Approach
- 2.3.3 Top-down Approach
- 2.3.4 Growth Forecast
- 2.4 Market Study Assumptions
- 2.5 Data Sources
- SECTION 3 - EXECUTIVE SUMMARY
- 3.1 Global Eubiotics Market, by Product
- 3.2 Global Eubiotics Market, by Form
- 3.3 Global Eubiotics Market, by Application
- 3.4 Global Eubiotics Market, by End Use
- 3.5 Global Eubiotics Market, by Geography
- 3.6 Market Position Grid
- SECTION 4 - PREMIUM INSIGHTS
- 4.1 Regulatory Framework
- 4.1.1 Standards
- 4.1.2 Regulatory Landscape
- 4.2 Value Chain Analysis
- 4.3 Supply Chain Analysis
- 4.4 COVID-19 Impact
- 4.5 Russia-Ukraine War Impact
- 4.6 PORTER's Five Force Analysis
- 4.7 PESTLE Analysis
- 4.8 SWOT Analysis
- 4.9 Go to Market Strategy
- 4.10 Opportunity Orbit
- 4.11 Multivariate Modelling
- 4.12 Pricing Analysis
- SECTION 5 - MARKET DYNAMICS
- 5.1 Trends
- 5.1.1 Shift towards natural alternatives
- 5.1.2 Focus on gut health
- 5.1.3 Trend 3
- 5.2 Drivers
- 5.2.1 Expansion in poultry and swine sectors
- 5.2.2 Demand for performance enhancement
- 5.2.3 Driver 3
- 5.2.4 Driver 4
- 5.3 Restraints
- 5.3.1 Limited awareness
- 5.3.2 Resistance to change
- 5.3.3 Restraint 3
- 5.4 Opportunities
- 5.4.1 Integration with digital agriculture
- 5.4.2 Development of tailored solutions
- 5.4.3 Opportunity 3
- 5.4.4 Opportunity 4
- 5.5 Challenges
- 5.5.1 Quality and stability issues
- 5.5.2 Supply chain vulnerabilities
- 5.5.3 Challenge 3
- SECTION 6 - GLOBAL EUBIOTICS MARKET, BY PRODUCT
- 6.1 Product Summary
- 6.2 Market Attractive Index
- 6.3 Global Eubiotics Market, by Product (2019-2032)
- SECTION 7 - GLOBAL EUBIOTICS MARKET, BY FORM
- 7.1 Form Summary
- 7.2 Market Attractive Index
- 7.3 Global Eubiotics Market, by Form (2019-2032)
- SECTION 8 - GLOBAL EUBIOTICS MARKET, BY APPLICATION
- 8.1 Application Summary
- 8.2 Market Attractive Index
- 8.3 Global Eubiotics Market, by Application (2019-2032)
- SECTION 9 - GLOBAL EUBIOTICS MARKET, BY END USE
- 9.1 End Use Summary
- 9.2 Market Attractive Index
- 9.3 Global Eubiotics Market, by End Use (2019-2032)
- SECTION 10 - GLOBAL EUBIOTICS MARKET, BY GEOGRAPHY
- 10.1 Regional Summary
- 10.2 Market Attractive Index
- 10.3 Global Eubiotics Market, by Geography (2019-2032)
- SECTION 11 - NORTH AMERICA EUBIOTICS MARKET
- 11.1 North America Summary
- 11.2 Market Attractive Index
- 11.3 North America Eubiotics Market, by Product (2019-2032)
- 11.4 North America Eubiotics Market, by Form (2019-2032)
- 11.5 North America Eubiotics Market, by Application (2019-2032)
- 11.6 North America Eubiotics Market, by End Use (2019-2032)
- 11.7 North America Eubiotics Market, by Country (2019-2032)
- 11.7.1 U.S.
- 11.7.2 Canada
- 11.7.3 Mexico
- 11.7.4 Rest of North America
- SECTION 12 - EUROPE EUBIOTICS MARKET
- 12.1 Europe Summary
- 12.2 Market Attractive Index
- 12.3 Europe Eubiotics Market, by Product (2019-2032)
- 12.4 Europe Eubiotics Market, by Form (2019-2032)
- 12.5 Europe Eubiotics Market, by Application (2019-2032)
- 12.6 Europe Eubiotics Market, by End Use (2019-2032)
- 12.7 Europe Eubiotics Market, by Country (2019-2032)
- 12.7.1 Germany
- 12.7.2 U.K.
- 12.7.3 France
- 12.7.4 Italy
- 12.7.5 Spain
- 12.7.6 Russia
- 12.7.7 The Netherlands
- 12.7.8 Belgium
- 12.7.9 Turkey
- 12.7.10 Rest of Europe
- SECTION 13 - ASIA-PACIFIC EUBIOTICS MARKET
- 13.1 Asia-Pacific Summary
- 13.2 Market Attractive Index
- 13.3 Asia-Pacific Eubiotics Market, by Product (2019-2032)
- 13.4 Asia-Pacific Eubiotics Market, by Form (2019-2032)
- 13.5 Asia-Pacific Eubiotics Market, by Application (2019-2032)
- 13.6 Asia-Pacific Eubiotics Market, by End Use (2019-2032)
- 13.7 Asia-Pacific Eubiotics Market, by Country (2019-2032)
- 13.7.1 China
- 13.7.2 India
- 13.7.3 Japan
- 13.7.4 South Korea
- 13.7.5 Singapore
- 13.7.6 Malaysia
- 13.7.7 Australia
- 13.7.8 Thailand
- 13.7.9 Philippines
- 13.7.10 Rest of Asia-Pacific
- SECTION 14 - SOUTH AMERICA EUBIOTICS MARKET
- 14.1 South America Summary
- 14.2 Market Attractive Index
- 14.3 South America Eubiotics Market, by Product (2019-2032)
- 14.4 South America Eubiotics Market, by Form (2019-2032)
- 14.5 South America Eubiotics Market, by Application (2019-2032)
- 14.6 South America Eubiotics Market, by End Use (2019-2032)
- 14.7 South America Eubiotics Market, by Country (2019-2032)
- 14.7.1 Brazil
- 14.7.2 Argentina
- 14.7.3 Chile
- 14.7.4 Colombia
- 14.7.5 Rest of South America
- SECTION 15 - MIDDLE EAST AND AFRICA EUBIOTICS MARKET
- 15.1 Middle East and Africa Summary
- 15.2 Market Attractive Index
- 15.3 Middle East and Africa Eubiotics Market, by Product (2019-2032)
- 15.4 Middle East and Africa Eubiotics Market, by Form (2019-2032)
- 15.5 Middle East and Africa Eubiotics Market, by Application (2019-2032)
- 15.6 Middle East and Africa Eubiotics Market, by End Use (2019-2032)
- 15.7 Middle East and Africa Eubiotics Market, by Country (2019-2032)
- 15.7.1 Kingdom of Saudi Arabia
- 15.7.2 South Africa
- 15.7.3 U.A.E.
- 15.7.4 Egypt
- 15.7.5 Rest of Middle East and Africa
- SECTION 16 - COMPANY SHARE ANALYSIS
- 16.1 Global Eubiotics Market, Company Share Analysis
- 16.2 North America Eubiotics Market, Company Share Analysis
- 16.3 Europe Eubiotics Market, Company Share Analysis
- 16.4 Asia-Pacific Eubiotics Market, Company Share Analysis
- SECTION 17 - COMPANY PROFILES
- 17.1 DSM
- 17.1.1 Company Snapshot
- 17.1.2 Financial Overview
- 17.1.3 Product Portfolio
- 17.1.4 Recent Developments
- 17.2 Novus International, Inc.
- 17.2.1 Company Snapshot
- 17.2.2 Financial Overview
- 17.2.3 Product Portfolio
- 17.2.4 Recent Developments
- 17.3 UAS Laboratories
- 17.3.1 Company Snapshot
- 17.3.2 Financial Overview
- 17.3.3 Product Portfolio
- 17.3.4 Recent Developments
- 17.4 Lallemand, Inc.
- 17.4.1 Company Snapshot
- 17.4.2 Financial Overview
- 17.4.3 Product Portfolio
- 17.4.4 Recent Developments
- 17.5 Calpis Co., Ltd.
- 17.5.1 Company Snapshot
- 17.5.2 Financial Overview
- 17.5.3 Product Portfolio
- 17.5.4 Recent Developments
- 17.6 Advanced BioNutrition Corp
- 17.6.1 Company Snapshot
- 17.6.2 Financial Overview
- 17.6.3 Product Portfolio
- 17.6.4 Recent Developments
- 17.7 BENEO
- 17.7.1 Company Snapshot
- 17.7.2 Financial Overview
- 17.7.3 Product Portfolio
- 17.7.4 Recent Developments
- 17.8 BEHN MEYER
- 17.8.1 Company Snapshot
- 17.8.2 Financial Overview
- 17.8.3 Product Portfolio
- 17.8.4 Recent Developments
- 17.9 Lesaffre Group
- 17.9.1 Company Snapshot
- 17.9.2 Financial Overview
- 17.9.3 Product Portfolio
- 17.9.4 Recent Developments
- 17.10 Kemin Industries, Inc.
- 17.10.1 Company Snapshot
- 17.10.2 Financial Overview
- 17.10.3 Product Portfolio
- 17.10.4 Recent Developments
- SECTION 18 - RELATED REPORTS
- SECTION 19 - DISCLAIMER
RESEARCH METHODOLOGY
RESEARCH AND DATA COLLECTION
- Research articles published on Technium
- Science and MDPI
- Research publications by government approved associations and societies
DATA PRE-PROCESSING
The term "data pre-processing" refers to the collection of procedures and methods used to clean, modify, and make ready for analysis the raw data gathered during research and data collection. The completion of this phase is necessary to guarantee that the data are reliable, consistent, and appropriate for statistical analysis and other data-driven tasks. The data pre-processing ensures that the information gathered from research and data collection is comparable and expressed in standard units, by the integration of missing data pointers and algorithmic approaches.
MODELING AND FORECASTING
QUALITY ASSURANCE AND OUTPUT
Quality assurance and output involves the process of validation, adjustments, further publications of key market indicators. Extensive plausibility and consistency tests are performed on derived time series to ensure the high degree of quality of our market analysis. This quality assurance procedure also includes rigorous inspection, validation, and editing by an experienced management team to assure the dependability of the published data.